Literature DB >> 15339710

A profile of OxyContin addiction.

Lon R Hays1.   

Abstract

OxyContin is a controlled-released form of oxycodone indicated for the management of moderate to severe pain. OxyContin diversion and abuse has become a major problem in certain areas of the United States, particularly rural areas and Appalachia. This study undertakes an 18-month retrospective chart review at a private freestanding psychiatric facility to develop a profile of OxyContin addicts seeking treatment. There were 579 admissions to the Addictive Disease Unit of this facility from October 2000 to March 2002, with 298 of these admissions being for the treatment of opioid abuse or dependence. One hundred and eighty seven of these individuals were dependent on OxyContin, using an average dose of 184 milligrams of OxyContin per day. The OxyContin dependent individuals tended to show a progression from p.o. use to either snorting or i.v. use. The author concludes that a sociocultural understanding is needed to better treat these addicts as is improved communication between the pain treatment community and the addiction treatment community.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339710     DOI: 10.1300/J069v23n04_01

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  36 in total

1.  Assessment of a formulation designed to be crush-resistant in prescription opioid abusers.

Authors:  Suzanne K Vosburg; Jermaine D Jones; Jeanne M Manubay; Judy B Ashworth; Irma H Benedek; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2012-06-20       Impact factor: 4.492

2.  Perceived need for substance abuse treatment among illicit stimulant drug users in rural areas of Ohio, Arkansas, and Kentucky.

Authors:  Russel S Falck; Jichuan Wang; Robert G Carlson; Laura L Krishnan; Carl Leukefeld; Brenda M Booth
Journal:  Drug Alcohol Depend       Date:  2007-07-02       Impact factor: 4.492

Review 3.  Abuse-deterrent opioid formulations: are they a pipe dream?

Authors:  Nathaniel Katz
Journal:  Curr Rheumatol Rep       Date:  2008-01       Impact factor: 4.592

4.  Regulation of gene expression in brain tissues of rats repeatedly treated by the highly abused opioid agonist, oxycodone: microarray profiling and gene mapping analysis.

Authors:  Hazem E Hassan; Alan L Myers; Insong J Lee; Hegang Chen; Andrew Coop; Natalie D Eddington
Journal:  Drug Metab Dispos       Date:  2010-01       Impact factor: 3.922

Review 5.  Opioid use and misuse: health impact, prevalence, correlates and interventions.

Authors:  Maria Bolshakova; Ricky Bluthenthal; Steve Sussman
Journal:  Psychol Health       Date:  2019-06-08

6.  [Another "War on Drugs" : A war against addicts and a "roll-back" for patients needing opioids?]

Authors:  C Maier
Journal:  Schmerz       Date:  2018-06       Impact factor: 1.107

Review 7.  Strategies to prevent opioid misuse, abuse, and diversion that may also reduce the associated costs.

Authors:  Kathryn L Hahn
Journal:  Am Health Drug Benefits       Date:  2011-03

8.  The Diversion of Prescription Opioid Analgesics.

Authors:  James A Inciardi; Hilary L Surratt; Yamilka Lugo; Theodore J Cicero
Journal:  Law Enforc Exec Forum       Date:  2007-11

9.  Rates of substance use of American Indian students in 8th, 10th, and 12th grades living on or near reservations: update, 2009-2012.

Authors:  Linda R Stanley; Susan D Harness; Randall C Swaim; Fred Beauvais
Journal:  Public Health Rep       Date:  2014 Mar-Apr       Impact factor: 2.792

10.  Formulation optimization of hot-melt extruded abuse deterrent pellet dosage form utilizing design of experiments.

Authors:  Sindhuri Maddineni; Sunil Kumar Battu; Joe Morott; Majumdar Soumyajit; Michael A Repka
Journal:  J Pharm Pharmacol       Date:  2013-08-20       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.